Ambev S.A.
NYSE:ABEVBeverages - Alcoholic
-$0.02 today
- Market cap
- $42.89B
- Beta
- 0.27
- P/E (TTM)
- 16.2
- EPS (TTM)
- $1.00
- Dividend yield
- 9.76%
Volume 11.24M
Average 27.73M
ABEV Accounts Payables
Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.
Ambev S.A.NYSE: ABEV
Accounts Payables · Q2 FY2026 · quarter ended Jun 2026
Accounts payables turns negative
Q2 FY2026 accounts payables was -R$1.42B, compared with R$0 a year earlier. Trailing-twelve-month accounts payables was -R$1.42B.
Context
- Accounts payables amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Accounts payables increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts payables holds near -R$1.42B or moves back toward the trailing-twelve-month quarterly average of -R$354.18M.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Payables history
BRL · from the cash flow
- Latest · FY2025
- 0 BRL
- Year-over-year change
- —
| Period | Period end | Accounts Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Accounts Payables vs competitors
How ABEV compares with its peers on the latest reported figures
- Peers report in different currencies, so accounts payables is compared through growth and share of revenue rather than absolute size.
- Accounts payables amounts to 1.6% of revenue for ABEV, versus a peer median of 0.2%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | R$1.42B BRL | — | — | 1.6% | |
| LTM Jun 2026 | $730.7M USD | — | — | 1.5% | |
| FY2025 | $298.92M USD | +39.3% | — | 0.5% | |
| LTM Aug 2026 | $16.1M USD | -19.5% | — | 0.2% | |
| LTM Jun 2026 | $0 USD | — | +160.7% | 0.0% | |
| LTM Mar 2026 | CLP 0 CLP | — | — | 0.0% | |
| Peer median (excluding ABEV) | — | +9.9% | +160.7% | 0.2% | |
Competitors are the stored peer set for ABEV. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 13.12B | 14.89B | 14.96B | 14.85B | 15.99B |
| Depreciation & Amortization | 5.4B | 5.96B | 6.42B | 7.13B | 6.83B |
| Deferred Income Tax | 853.2M | (316M) | 253.8M | 4.91B | 3.7B |
| Stock-Based Compensation | 387.6M | 313.9M | 331.6M | 400.9M | 454.2M |
| Change in Working Capital | 3B | (2.68B) | (296.1M) | (165M) | (1.62B) |
| Accounts Receivables | 341.4M | (322.5M) | (1.37B) | 220.4M | (312.9M) |
| Inventory | (3.5B) | (3.09B) | 1.3B | (1.7B) | (30.9M) |
| Accounts Payables | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital | 6.16B | 726.6M | (223.1M) | 1.32B | (1.27B) |
| Other Non-Cash Items | 141.8M | 2.48B | 3.04B | (1.03B) | (908.2M) |
| Operating Cash Flow | 22.9B | 20.64B | 24.71B | 26.1B | 24.45B |
| Capital Expenditures | (7.68B) | (6.53B) | (6B) | (4.75B) | (4.59B) |
| Acquisitions (Net) | (133.3M) | (33M) | (52.8M) | 10.3M | (91.6M) |
| Purchases of Investments | (241.3M) | (30M) | (6.3M) | (888.6M) | (441.5M) |
| Sales of Investments | 0 | 1.41B | 136.4M | 0 | 0 |
| Other Investing Activities | 316.7M | 178.9M | 160.8M | 164M | 173.5M |
| Investing Cash Flow | (7.74B) | (5B) | (5.77B) | (5.46B) | (4.95B) |
| Debt Repayment | (2.8B) | (810M) | (1.36B) | (1.45B) | (1.28B) |
| Common Stock Issued | 9.1M | 23.8M | 14.5M | 17.5M | 0 |
| Common Stock Repurchased | (44.2M) | (54.1M) | (119M) | (467.6M) | (1.93B) |
| Dividends Paid | (11.12B) | (12.24B) | (11.92B) | (4.06B) | (20.46B) |
| Other Financing Activities | (2.09B) | (3.26B) | (2.73B) | (4.4B) | (3.1B) |
| Financing Cash Flow | (16.04B) | (16.34B) | (16.12B) | (10.35B) | (26.77B) |
| Effect of Forex Changes | 382.6M | (1.05B) | (1.62B) | 2.25B | (2.69B) |
| Net Change in Cash | (493.1M) | (1.75B) | 1.21B | 12.54B | (9.96B) |
| Free Cash Flow | 15.22B | 14.11B | 18.71B | 21.35B | 19.86B |
Ambev S.A.
NYSE:ABEV
Intrinsic Alpha fair value
Locked
Current Price
$2.70
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.